MDT

86.05

+0.2%↑

A

114.6

+0.02%↑

VEEV

173.01

-0.02%↓

HQY

84.23

+1.14%↑

PHR.US

8.4

-1.18%↓

MDT

86.05

+0.2%↑

A

114.6

+0.02%↑

VEEV

173.01

-0.02%↓

HQY

84.23

+1.14%↑

PHR.US

8.4

-1.18%↓

MDT

86.05

+0.2%↑

A

114.6

+0.02%↑

VEEV

173.01

-0.02%↓

HQY

84.23

+1.14%↑

PHR.US

8.4

-1.18%↓

MDT

86.05

+0.2%↑

A

114.6

+0.02%↑

VEEV

173.01

-0.02%↓

HQY

84.23

+1.14%↑

PHR.US

8.4

-1.18%↓

MDT

86.05

+0.2%↑

A

114.6

+0.02%↑

VEEV

173.01

-0.02%↓

HQY

84.23

+1.14%↑

PHR.US

8.4

-1.18%↓

Search

Quanterix Corp

Deschisă

SectorSănătate

3.73 5.37

Rezumat

Modificarea prețului

24h

Curent

Minim

3.36

Maxim

3.84

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

450

EBITDA

15M

-17M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+115.52% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-135M

161M

Deschiderea anterioară

-1.64

Închiderea anterioară

3.73

Sentimentul știrilor

By Acuity

50%

50%

163 / 349 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

1 apr. 2026, 22:56 UTC

Evenimente importante

Australian PM Set To Announce Interest-Free Loans For Businesses, Farmers

1 apr. 2026, 20:50 UTC

Achiziții, Fuziuni, Preluări

Gilead Extends Deadline on Tender Offer to Acquire Arcellx

1 apr. 2026, 23:55 UTC

Market Talk

Gold Rises on Hopes for Early End to U.S.-Iran Conflict -- Market Talk

1 apr. 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Continued Hopes for U.S. Ending Iran War -- Market Talk

1 apr. 2026, 23:23 UTC

Evenimente importante

South Korea Consumer Inflation Accelerates on Mideast Energy Shock -- Update

1 apr. 2026, 23:07 UTC

Câștiguri

Shake Shack Leans on Loyalty Program and Tech to Drive Growth -- Barrons.com

1 apr. 2026, 23:02 UTC

Evenimente importante

South Korea Consumer Inflation Accelerates on Mideast Energy Shock

1 apr. 2026, 23:00 UTC

Evenimente importante

S Korea Mar CPI +0.3% on Month; +0.6% Forecast

1 apr. 2026, 23:00 UTC

Evenimente importante

S Korea Mar Core CPI +2.2% on Year, +0.1% on Month

1 apr. 2026, 23:00 UTC

Evenimente importante

S Korea Mar CPI +2.2% on Year; +2.4% Forecast

1 apr. 2026, 22:39 UTC

Câștiguri

Nike Can't Fix Its China Problem and That's Tanking Its Stock -- Update

1 apr. 2026, 22:08 UTC

Market Talk

KKR BDC Joins Others in Capping Withdrawals at 5% -- Market Talk

1 apr. 2026, 22:00 UTC

Evenimente importante

Mideast War Rekindles Asia Inflation Risk, Says DBS Chief Economist -- Interview

1 apr. 2026, 22:00 UTC

Evenimente importante

DBS Chief Economist: Rate Hikes Seem Likely in Japan, Singapore, Australia

1 apr. 2026, 22:00 UTC

Evenimente importante

DBS Chief Economist: BOK Could Also Take Proactive Approach Like RBA

1 apr. 2026, 22:00 UTC

Evenimente importante

DBS Chief Economist: India Vulnerable to War Imapct on Both Trade, Energy

1 apr. 2026, 22:00 UTC

Evenimente importante

DBS Chief Economist: China, Malaysia Looks Relatively Well-Insulated From War Fallout

1 apr. 2026, 22:00 UTC

Evenimente importante

DBS Chief Economist: Mideast Crisis Won't Hurt Asia Growth Much, Inflation a Bigger Issue

1 apr. 2026, 22:00 UTC

Evenimente importante

Inflationary Impact of Mideast Conflict Seems Inevitable, DBS Group Chief Economist Says

1 apr. 2026, 21:56 UTC

Achiziții, Fuziuni, Preluări

BHP Completes $4.3 Billion Silver Streaming Agreement With Wheaton Precious Metals

1 apr. 2026, 21:31 UTC

Evenimente importante

End to Iran War Could Trigger Relief Rally in These 2 Assets -- Barrons.com

1 apr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

1 apr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

1 apr. 2026, 20:38 UTC

Câștiguri

Why Nike Stock Is in 'Penalty Box' After Earnings Beat -- Barrons.com

1 apr. 2026, 20:31 UTC

Achiziții, Fuziuni, Preluări

Arsenal Capital Partners Completes Sale of ATP Adhesive Systems to Henkel

1 apr. 2026, 20:16 UTC

Achiziții, Fuziuni, Preluări

Gilead: Tender Offer Extended to Expire at 5 p.m. EDT on April 24 >GILD

1 apr. 2026, 20:16 UTC

Achiziții, Fuziuni, Preluări

Gilead: Offer Remains at a Purchase Price of $115.00 per Shr >GILD

1 apr. 2026, 20:13 UTC

Achiziții, Fuziuni, Preluări

Gilead Extends Tender Offer To Acquire Arcellx >GILD

1 apr. 2026, 20:07 UTC

Market Talk

Mexican Manufacturing Indexes Pick Up in March -- Market Talk

1 apr. 2026, 20:07 UTC

Achiziții, Fuziuni, Preluări

Why 2026 Is Biotech's Comeback Year -- Barrons.com

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

115.52% sus

Prognoză pe 12 luni

Medie 7.5 USD  115.52%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

163 / 349 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat